| ISIN | CH0542826950 |
|---|---|
| Valor Number | 54282695 |
| Bloomberg Global ID | |
| Fund Name | Alpora Innovation Europa Fonds EUR E |
| Fund Provider |
AWEA Fonds AG
Zug, Switzerland Phone: +41 41 726 71 71 Web: https://www.awea.ch |
| Fund Provider | AWEA Fonds AG |
| Representative in Switzerland | |
| Distributor(s) |
AWEA Fonds AG Zug Phone: +41 41 726 71 71 |
| Asset Class | Other Funds |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | N/A |
| Peculiarities |
| Current Price * | 126.81 EUR | 06.11.2025 |
|---|---|---|
| Previous Price * | 128.27 EUR | 05.11.2025 |
| 52 Week High * | 136.37 EUR | 21.02.2025 |
| 52 Week Low * | 108.62 EUR | 09.04.2025 |
| NAV * | 126.81 EUR | 06.11.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 34,408,663 | |
| Unit/Share Assets *** | 1,302,320 | |
| Trading Information SIX | ||
| YTD Performance | -0.50% |
31.12.2024 - 06.11.2025
31.12.2024 06.11.2025 |
|---|---|---|
| YTD Performance (in CHF) | -1.35% |
31.12.2024 - 06.11.2025
31.12.2024 06.11.2025 |
| 1 month | -3.71% |
06.10.2025 - 06.11.2025
06.10.2025 06.11.2025 |
| 3 months | +2.24% |
06.08.2025 - 06.11.2025
06.08.2025 06.11.2025 |
| 6 months | +2.88% |
06.05.2025 - 06.11.2025
06.05.2025 06.11.2025 |
| 1 year | -1.46% |
06.11.2024 - 06.11.2025
06.11.2024 06.11.2025 |
| 2 years | -3.41% |
06.11.2023 - 06.11.2025
06.11.2023 06.11.2025 |
| 3 years | -1.26% |
07.11.2022 - 06.11.2025
07.11.2022 06.11.2025 |
| 5 years | +10.54% |
06.11.2020 - 06.11.2025
06.11.2020 06.11.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AstraZeneca PLC | 4.43% | |
|---|---|---|
| Novo Nordisk AS Class B | 4.17% | |
| L'Oreal SA | 3.27% | |
| Deutsche Telekom AG | 3.25% | |
| Shell PLC | 3.22% | |
| ABB Ltd | 3.14% | |
| Alcon Inc | 2.95% | |
| Wolters Kluwer NV | 2.91% | |
| ASM International NV | 2.77% | |
| Equinor ASA | 2.75% | |
| Last data update | 31.12.2024 | |
| TER | 2.09% |
|---|---|
| TER date | 31.12.2024 |
| Performance Fee *** | |
| PTR | 186.00% |
| Max. Management Fee *** | 2.00% |
| Ongoing Charges *** | 2.09% |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |